William Blair Initiates Coverage On Talkspace with Outperform Rating
William Blair analyst Ryan Daniels initiates coverage on Talkspace (NASDAQ:TALK) with a Outperform rating.
William Blair Initiates Coverage On Sprinklr with Outperform Rating
William Blair analyst Arjun Bhatia initiates coverage on Sprinklr (NYSE:CXM) with a Outperform rating.
Scotiabank Initiates Coverage On WELL Health Technologies with Sector Perform Rating, Announces Price Target of $10
Scotiabank initiates coverage on WELL Health Technologies (OTC:WLYYF) with a Sector Perform rating and announces Price Target of $10.
JP Morgan Initiates Coverage On Bright Health Gr with Neutral Rating, Announces Price Target of $19
JP Morgan analyst Lisa Gill initiates coverage on Bright Health Gr (NYSE:BHG) with a Neutral rating and announces Price Target of $19.
Raymond James Initiates Coverage On Doximity with Outperform Rating, Announces Price Target of $60
Raymond James analyst Brian Peterson initiates coverage on Doximity (NYSE:DOCS) with a Outperform rating and announces Price Target of $60.
Needham Initiates Coverage On Doximity with Buy Rating, Announces Price Target of $62
Needham analyst Scott Berg initiates coverage on Doximity (NYSE:DOCS) with a Buy rating and announces Price Target of $62.
RBC Capital Assumes ADT at Outperform, Announces Price Target of $12
RBC Capital analyst Ashish Sabadra assumes ADT (NYSE:ADT) with a Outperform rating and announces Price Target of $12.
RBC Capital Initiates Coverage On Pet Valu Holdings with Sector Perform Rating, Announces Price Target of C$29
RBC Capital analyst Irene Nattel initiates coverage on Pet Valu Holdings (TSX:PET) with a Sector Perform rating and announces Price Target of C$29.
Guggenheim Initiates Coverage On Monte Rosa Therapeutics with Buy Rating, Announces Price Target of $30
Guggenheim initiates coverage on Monte Rosa Therapeutics (NASDAQ:GLUE) with a Buy rating and announces Price Target of $30.
Cowen & Co. Initiates Coverage On MasTec with Outperform Rating, Announces Price Target of $120
Cowen & Co. analyst Marc Bianchi initiates coverage on MasTec (NYSE:MTZ) with a Outperform rating and announces Price Target of $120.